Joachim Diebold

Joachim Diebold

UNVERIFIED PROFILE

Are you Joachim Diebold?   Register this Author

Register author
Joachim Diebold

Joachim Diebold

Publications by authors named "Joachim Diebold"

Are you Joachim Diebold?   Register this Author

88Publications

2064Reads

20Profile Views

Capmatinib and Osimertinib Combination Therapy for EGFR-Mutant Lung Adenocarcinoma.

J Thorac Oncol 2020 Jan;15(1):e13-e15

Cantonal Hospital Lucerne, Lucerne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2019.07.027DOI Listing
January 2020

Comment on: Wiser et al. Ovarian cancer in Switzerland: incidence and treatment according to hospital registry data. Swiss Med Wkly.2018;148:w14647.

Swiss Med Wkly 2020 Jan 7;150:w20179. Epub 2020 Feb 7.

Division of Chronic Disease Epidemiology, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Switzerland / Cancer Registry of the canton Zurich and Zug, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4414/smw.2020.20179DOI Listing
January 2020

Retinoblastoma with late metastatic spread-a case report.

Pediatr Blood Cancer 2019 06 5;66(6):e27656. Epub 2019 Feb 5.

Hopp Children's Cancer Center (KiTZ), Heidelberg University Hospital, Heidelberg, Germany.

View Article

Download full-text PDF

Source
https://onlinelibrary.wiley.com/doi/abs/10.1002/pbc.27656
Publisher Site
http://dx.doi.org/10.1002/pbc.27656DOI Listing
June 2019

Ileoileal intussusception in unspecific recurrent abdominal pain in adult: A case report.

SAGE Open Med Case Rep 2018 9;6:2050313X18792814. Epub 2018 Aug 9.

Emergency Department, University Hospital Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2050313X18792814DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6088483PMC
August 2018

Multi-laboratory proficiency testing of clinical cancer genomic profiling by next-generation sequencing.

Pathol Res Pract 2018 Jul 22;214(7):957-963. Epub 2018 May 22.

Department of Pathology and Molecular Pathology, University Hospital Zurich, 8091, Zurich, Switzerland; Senckenberg Institute of Pathology, University Hospital Frankfurt, 60590, Frankfurt, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.prp.2018.05.020DOI Listing
July 2018

Population-level effect of molecular testing and targeted therapy in patients with advanced pulmonary adenocarcinoma: a prospective cohort study.

Virchows Arch 2018 Apr 2;472(4):581-588. Epub 2017 Dec 2.

Department of Medical Oncology, Cantonal Hospital Lucerne, Lucerne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00428-017-2268-yDOI Listing
April 2018

Incidence Trends of Cervical Cancer and Its Precancerous Lesions in Women of Central Switzerland from 2000 until 2014.

Front Med (Lausanne) 2018 16;5:58. Epub 2018 Mar 16.

Department of Obstetrics and Gynecology, Cantonal Hospital of Lucerne, Lucerne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fmed.2018.00058DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5864899PMC
March 2018

Human placental growth hormone in ectopic pregnancy: Detection in maternal blood, immunohistochemistry and potential clinical implication.

Growth Horm IGF Res 2017 12 14;37:13-18. Epub 2017 Oct 14.

Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Klinikum der Universität München, Ludwig-Maximilians-Universität München, Marchioninistr. 15, 81377 München, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ghir.2017.10.004DOI Listing
December 2017

Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry.

J Clin Oncol 2017 May 13;35(13):1403-1410. Epub 2017 Mar 13.

Oliver Gautschi, Kristin Zeidler, and Joachim Diebold, Lucerne Cantonal Hospital, Luzern; Patrizia Froesch, Ente Ospedaliero Cantonale, Bellinzona; Martin Früh, Kantonsspital St Gallen, St Gallen; Sacha I. Rothschild, University Hospital Basel, Basel, Switzerland; Julie Milia and Julien Mazières, Hôpital Larrey; Thomas Filleron, Institut Universitaire du Cancer, Claudius Regaud, Toulouse; Benjamin Besse and Jordi Remon-Masip, Institute Gustave Roussy, Villejuif; Gérard Zalcman, University Hospital Bichat, Paris; Isabelle Monnet, Centre Hospitalier Intercommunal de Creteil, Creteil; Florian Cabillic, Université de Rennes 1, Rennes, France; Juergen Wolf and Sebastian Michels, Center for Integrated Oncology, Cologne; Georg Pall, Fachkliniken Wangen, Wangen Im Allgäu; Arne Warth, Heidelberg University Hospital; Thomas Muley, Thoraxklinik at University of Heidelberg and Translational Lung Research Center, Heidelberg, Germany; David P. Carbone and Dwight Owen, Ohio State University Comprehensive Cancer Center, Columbus; Vamsidhar Velcheti, Cleveland Clinic, Pepper Pike, OH; Ross Camidge and Vignhesh Narayanan, University of Colorado, Denver; Robert C. Doebele, University of Colorado, Aurora, CO; Pasi A. Janne and Mark M. Awad, Dana-Farber Cancer Institute, Boston, MA; Daniel D. Karp, The University of Texas MD Anderson Cancer Center, Houston, TX; Heather A. Wakelee and Joel W. Neal, Stanford University, Stanford; Sai-Hong Ignatius Ou, University of California, Irvine, Orange; David R. Gandara and Jonathan W. Riess, University of California, Davis Cancer Center, Sacramento, CA; Alexander Drilon, Memorial Sloan Kettering Cancer Center, New York, NY; Nir Peled, Davidoff Cancer Center, Petach Tiqwa, Israël; Chul-Cho Byoung, Yonseï Cancer Center, Seoul, Republic of Korea; Michael Van Den Heuvel, Netherlands Cancer Institute, Amsterdam, the Netherlands; Tony S.K. Mok, The Chinese University of Hong Kong, Hong Kong, Special Administrative Region, People's Republic of China; James C.H. Yang and Jin-Yuan Shih, National Taiwan University Hospital, Taipei, Republic of China; Sanjay Popat, Royal Marsden Hospital, London, United Kingdom; and Rafael Rosell and Niki Karachaliou, Catalan Institute of Oncology, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.9352DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5559893PMC
May 2017

Response to Pembrolizumab in a Patient with Relapsing Thymoma.

J Thorac Oncol 2016 12 4;11(12):e147-e149. Epub 2016 Aug 4.

Department of Medical Oncology, Cantonal Hospital Lucerne, Lucerne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2016.07.018DOI Listing
December 2016

A Cost-Effectiveness Analysis of Nivolumab versus Docetaxel for Advanced Nonsquamous NSCLC Including PD-L1 Testing.

J Thorac Oncol 2016 11 14;11(11):1846-1855. Epub 2016 Jun 14.

Swiss Group for Clinical Cancer Research Coordinating Centre, Bern, Switzerland; Medical Oncology, Department of Internal Medicine, Cantonal Hospital Lucerne, Lucerne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2016.05.032DOI Listing
November 2016

FDG PET/MRI Imaging of an Angiosarcoma in a Popliteal Aneurysm and Tibial Head After Popliteal Graft.

Clin Nucl Med 2016 Sep;41(9):e426-7

From the Departments of *Nuclear Medicine/Radiology, †Pathology, and ‡Orthopaedic Surgery, Cantonal Hospital Lucerne, Lucerne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLU.0000000000001300DOI Listing
September 2016

Diagnosing Nodular Regenerative Hyperplasia of the Liver Is Thwarted by Low Interobserver Agreement.

PLoS One 2015 8;10(6):e0120299. Epub 2015 Jun 8.

Department of Gastroenterology and Hepatology, VU University Medical Center, Amsterdam, the Netherlands; Department of Internal Medicine, Gastroenterology and Geriatrics, ORBIS Medical Center, Sittard-Geleen, the Netherlands.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0120299PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4459699PMC
February 2016

Targeted Therapy for Patients with BRAF-Mutant Lung Cancer: Results from the European EURAF Cohort.

J Thorac Oncol 2015 Oct;10(10):1451-7

*Tumorzentrum, Luzerner Kantonsspital, Luzern, Switzerland; †Hôpital Larrey, Centre Hospital-Universitaire, Université Paul Sabatier, Toulouse, France; ‡Institut Claudius Regaud IUCT-O, Toulouse, France; §Institut Gustave Roussy, Villejuif, France; ¶VU University Medical Center, Amsterdam, The Netherlands; ‖Center of Integrated Oncology Cologne, University Hospital Cologne, Cologne, Germany; #Centre Pluridisciplinaire d'Oncologie, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; **Onkologie/Hämatologie, Kantonsspital St. Gallen, St. Gallen, Switzerland; ††Medizinische Klinik, St. Claraspital, Basel, Switzerland; ‡‡Service de pneumologie et oncologie thoracique, Hopital Universitaire, Caen, France; §§University Hospital Essen, Essen, Germany; ¶¶University Hospital Zurich, Zurich, Switzerland; ‖‖Clinique Teissier, Valenciennes, France; ##Centre Hospitalier Intercommunal de Creteil, Créteil, France; ***University Hospital Innsbruck, Innsbruck, Austria; †††University Hospital Basel, Basel, Switzerland; ‡‡‡Heidelberg University Medical Center, Mannheim, Germany; §§§Hopital du Haut Lévèque, Pessac, France; ¶¶¶Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; and ‖‖‖Centre Hospitalier Universitaire, Université de Caen-Basse Normandie, Caen, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000625DOI Listing
October 2015

Screening for ALK in non-small cell lung carcinomas: 5A4 and D5F3 antibodies perform equally well, but combined use with FISH is recommended.

Lung Cancer 2015 Aug 21;89(2):104-9. Epub 2015 May 21.

Institute of Pathology, University Hospital Basel, Schoenbeinstrasse 40, 4031 Basel, Switzerland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2015.05.012DOI Listing
August 2015

Integrated CT-perfusion shows no meaningful correlation with PSA and presurgical Gleason score in patients with early prostate cancer.

Clin Imaging 2014 Nov-Dec;38(6):850-7. Epub 2014 Aug 2.

Department of Radiology and Nuclear Medicine, Lucerne Cantonal Hospital, Spitalstrasse 1, 6004 Lucerne, Switzerland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinimag.2014.07.011DOI Listing
June 2015

Rapid response to trastuzumab emtansine in a patient with HER2-driven lung cancer.

J Thorac Oncol 2015 Apr;10(4):e16-7

*Department of Medical Oncology, Cantonal Hospital, Luzern, Switzerland; †Department of Pathology, Cantonal Hospital, Luzern, Switzerland; and ‡Department of Nuclear Medicine, Cantonal Hospital, Luzern, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000424DOI Listing
April 2015

Crizotinib therapy for advanced lung adenocarcinoma and a ROS1 rearrangement: results from the EUROS1 cohort.

J Clin Oncol 2015 Mar 9;33(9):992-9. Epub 2015 Feb 9.

Julien Mazières, Damien Rouvière, and Julie D. Milia, Hôpital Larrey, Centre Hospitalier Universitaire, Université Paul Sabatier; Thomas Filleron, Institut Universitaire du Cancer, Toulouse; Gérard Zalcman, Centre Hospitalier Universitaire, Université de Caen-Basse Normandie, Caen; Pamela Biondani and Benjamin Besse, Gustave Roussy, Villejuif; Fabrice Barlesi, Aix-Marseille University, Assistance Publique Hôpitaux de Marseille, Marseille; Hervé Léna, Centre Hospitalier Universitaire, Rennes; Isabelle Monnet, Centre Hospitalier Intercommunal de Créteil, Créteil; Luc Thiberville, Centre Hospitalier Universitaire, Rouen; Nicolas Pecuchet, Institut Curie, Paris, France; Lucio Crinò, Medica-Azienda Ospedaliera, Perugia; Federico Cappuzzo, Istituto Toscano Tumori, Ospedale Civile, Livorno, Italy; Anne-Marie C. Dingemans, Maastricht University Medical Center, Maastricht; Egbert F. Smit, VU University Medical Center, Amsterdam, the Netherlands; Sacha I. Rothschild, University Hospital Basel, Medical Oncology, Basel; Christian Spirig, Klinik St Anna; Joachim Diebold and Oliver Gautschi, Cantonal Hospital Luzern, Lucerne, Switzerland; Rafal Dziadziuszko, Gdansk Medical University, Gdansk, Poland; Jurgen Wolf and Roman K. Thomas, Center of Integrated Oncology Köln-Bonn, University Hospital Cologne, University of Cologne; Frauke Leenders and Roman K. Thomas, University of Cologne; Johannes M. Heuckmann, Blackfield AG, Cologne, Germany.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2015/02/03/JCO.2014.58
Web Search
http://jco.ascopubs.org/content/early/2015/02/03/JCO.2014.58
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2014.58.3302
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.58.3302DOI Listing
March 2015

Human placental growth hormone: a potential new biomarker in gestational trophoblastic disease.

Gynecol Oncol 2015 Feb 29;136(2):264-8. Epub 2014 Nov 29.

Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Klinikum der Universität München, Campus Großhadern, Marchioninistr. 15, 81377 München, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2014.11.077DOI Listing
February 2015

Assessment of prostate cancer with dynamic contrast-enhanced computed tomography using an en bloc approach.

Invest Radiol 2014 Sep;49(9):571-8

From the *Department of Radiology and Nuclear Medicine, †Institute of Pathology, and ‡Department of Urology, Lucerne Cantonal Hospital, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLI.0000000000000055DOI Listing
September 2014

Cell-autonomous and non-cell-autonomous mechanisms of transformation by amplified FGFR1 in lung cancer.

Cancer Discov 2014 Feb 3;4(2):246-57. Epub 2013 Dec 3.

1Department of Translational Genomics, University of Cologne; 2Max-Planck-Institute for Neurological Research; Institutes of 3Pathology and 4Virology, University of Cologne;5Department I of Internal Medicine and Center for Integrated Oncology, University Hospital of Cologne; 6Blackfield AG, Cologne; 7Technical University Dortmund, Dortmund, Germany; 8Medical Oncology and 9Institute of Pathology, Cantonal Hospital, Luzern; 10Novartis Pharma AG, Basel, Switzerland; and 11Division of Natural Products Chemistry, CSIR-Indian Institute of Chemical Technology, Tarnaka, Hyderabad, India.

View Article

Download full-text PDF

Source
http://cancerdiscovery.aacrjournals.org/cgi/doi/10.1158/2159
Publisher Site
http://dx.doi.org/10.1158/2159-8290.CD-13-0323DOI Listing
February 2014

Experience in integrating ALK testing and crizotinib into the routine treatment of patients with non-small cell lung cancer.

Onkologie 2013 30;36(6):342-7. Epub 2013 Apr 30.

Department of Medicine, Medical Oncology, Cantonal Hospital, Lucerne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000351163DOI Listing
January 2014

Lung adenocarcinoma with BRAF G469L mutation refractory to vemurafenib.

Lung Cancer 2013 Nov 19;82(2):365-7. Epub 2013 Aug 19.

Department of Medical Oncology, Luzerner Kantonsspital, Luzern, Switzerland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2013.08.012DOI Listing
November 2013

Specialized pathology review in patients with ovarian cancer: results from a prospective study.

Int J Gynecol Cancer 2013 Oct;23(8):1376-82

*Universitäts-Frauenklinik Tübingen, Germany; †AGO Study Group, Wiesbaden, Germany; §Philipps-Universität Marburg, Koordinierungszentrum für klinische Studien, Marburg, Germany; ∥Luzerner Kantonsspital, Institute of Pathology, Luzern, Switzerland; ¶Institute of Pathology, Dueren, Germany; #Horst-Schmidt-Kliniken (HSK), Wiesbaden, Germany; ††Institute of Pathology, Mannheim, Germany; ‡Gynecologic Oncology Center, Kiel, Germany; and **Department Gynecology & Gynecologic Oncology, Kliniken Essen Mitte, Essen, Germany.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/ijgc/2013/10000/Specialized_Pat
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/IGC.0b013e3182a01813DOI Listing
October 2013

A patient with lung adenocarcinoma and RET fusion treated with vandetanib.

J Thorac Oncol 2013 May;8(5):e43-4

Department of Medical Oncology, Cantonal Hospital, Luzern, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e31828a4d07DOI Listing
May 2013

Simultaneous analysis of HER2 gene and protein on a single slide facilitates HER2 testing of breast and gastric carcinomas.

Am J Clin Pathol 2012 Dec;138(6):837-44

Institute of Pathology, Lucerne Cantonal Hospital, Lucerne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1309/AJCPL5IV0LAWSERGDOI Listing
December 2012

A patient with BRAF V600E lung adenocarcinoma responding to vemurafenib.

J Thorac Oncol 2012 Oct;7(10):e23-4

Department of Medicine, Luzerner Kantonsspital, Luzern, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e3182629903DOI Listing
October 2012

Her-2/neu and topoisomerase IIα in advanced breast cancer: a comprehensive FISH analysis of 245 cases.

Diagn Mol Pathol 2012 Jun;21(2):77-83

Department of Obstetrics and Gynecology, Campus Innenstadt, Ludwig-Maximilians-University Munich, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PDM.0b013e31823b6e43DOI Listing
June 2012

The c-MYC oncoprotein, the NAMPT enzyme, the SIRT1-inhibitor DBC1, and the SIRT1 deacetylase form a positive feedback loop.

Proc Natl Acad Sci U S A 2012 Jan 21;109(4):E187-96. Epub 2011 Dec 21.

Experimental and Molecular Pathology, Institute of Pathology, Ludwig-Maximilians-University Munich, D-80337 Munich, Germany.

View Article

Download full-text PDF

Source
http://www.pnas.org/cgi/doi/10.1073/pnas.1105304109
Publisher Site
http://dx.doi.org/10.1073/pnas.1105304109DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3268300PMC
January 2012

Mutational spectrum and therapy response of metastasized GIST in Central Switzerland - a population-based study.

Eur J Cancer 2011 Jun 18;47(9):1305-11. Epub 2011 Feb 18.

Institute of Pathology, Luzerner Kantonsspital, Lucerne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2011.01.012DOI Listing
June 2011

Synovial hemangioma of the knee joint with cystic invasion of the femur: a case report and review of the literature.

Arch Orthop Trauma Surg 2009 Feb 30;129(2):143-8. Epub 2008 Aug 30.

Department of Orthopaedic Surgery, Ludwigs-Maximilians-University Munich, Marchioninistr. 15, 81377 Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00402-008-0690-yDOI Listing
February 2009

Bilateral primary adrenal non-Hodgkin's lymphoma and primary adrenocortical carcinoma--review of the literature preoperative differentiation of adrenal tumors.

Endocr J 2008 Aug 19;55(4):625-38. Epub 2008 May 19.

Department of Surgery Innenstadt, University Hospital Munich, München, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1507/endocrj.k08e-035DOI Listing
August 2008

Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer.

Cell Cycle 2008 Aug 1;7(16):2591-600. Epub 2008 Aug 1.

Molecular Oncology, Max-Planck-Institute of Biochemistry, Martinsried, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cc.7.16.6533DOI Listing
August 2008

Molecular genetic aberrations of ovarian and uterine carcinosarcomas--a CGH and FISH study.

Virchows Arch 2008 Mar;452(3):259-68

Institute of Pathology, KSL Luzern, 6000 Luzern 16, Switzerland.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00428-007-0557-6
Publisher Site
http://dx.doi.org/10.1007/s00428-007-0557-6DOI Listing
March 2008

Broad, ectopic expression of the sperm protein PLCZ1 induces parthenogenesis and ovarian tumours in mice.

Development 2007 Nov;134(21):3941-52

Laboratory of Mammalian Molecular Embryology, RIKEN Center for Developmental Biology, 2-2-3 Minatojima Minamimachi, Chuo-ku, Kobe 650-0047, Japan.

View Article

Download full-text PDF

Source
http://dev.biologists.org/cgi/doi/10.1242/dev.007930
Publisher Site
http://dx.doi.org/10.1242/dev.007930DOI Listing
November 2007

Use of novel serum markers in clinical follow-up of Sertoli-Leydig cell tumours.

Clin Chem Lab Med 2007 ;45(5):657-61

Department of Obstetrics and Gynaecology, Campus Grosshadern, Ludwig-Maximilians-University, Munich, Germany.

View Article

Download full-text PDF

Source
https://www.degruyter.com/view/j/cclm.2007.45.issue-5/cclm.2
Publisher Site
http://dx.doi.org/10.1515/CCLM.2007.120DOI Listing
September 2007

KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants.

Gynecol Oncol 2006 Dec 30;103(3):883-7. Epub 2006 Jun 30.

Institute of Pathology, Ludwig-Maximilians-University of Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2006.05.029DOI Listing
December 2006

Gene deletion of MK2 inhibits TNF-alpha and IL-6 and protects against cerulein-induced pancreatitis.

Am J Physiol Gastrointest Liver Physiol 2006 Jun 19;290(6):G1298-306. Epub 2006 Jan 19.

Department of Internal Medicine II, Klinikum Grosshadern, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1152/ajpgi.00530.2005DOI Listing
June 2006

Nodular regenerative hyperplasia: a reversible entity associated with azathioprine therapy.

Eur J Gastroenterol Hepatol 2006 May;18(5):553-5

Department of Internal Medicine II, University of Munich, Klinikum Grosshadern, Marchioninistrasse 15, 81377 Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00042737-200605000-00018DOI Listing
May 2006

IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression.

Am J Physiol Gastrointest Liver Physiol 2005 Nov 28;289(5):G960-8. Epub 2005 Jul 28.

Department of Medicine II, University-Hospital Munich-Grosshadern, University of Munich, D-81377 Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1152/ajpgi.00126.2005DOI Listing
November 2005

Functional epigenomics identifies genes frequently silenced in prostate cancer.

Cancer Res 2005 May;65(10):4218-27

Molecular Oncology Group, Max-Planck-Institutes of Biochemistry, Martinsried and Institute of Pathology, Ludwig-Maximilians University, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-04-4407DOI Listing
May 2005

Prostate cancer is characterized by epigenetic silencing of 14-3-3sigma expression.

Oncogene 2004 Dec;23(56):9034-41

Molecular Oncology, Max-Planck-Institute of Biochemistry, Am Klopferspitz 18, D-82152 Martinsried/Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1208004DOI Listing
December 2004

Are gastrointestinal mucosal mast cells increased in patients with systemic mastocytosis?

Am J Clin Pathol 2004 Oct;122(4):560-5

Institute of Pathology, Ludwig-Maximilians University, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1309/2880-LF7Q-6XK3-HA3QDOI Listing
October 2004

Neoexpression of N-cadherin in E-cadherin positive colon cancers.

Int J Cancer 2004 Sep;111(5):711-9

Institut für Pathologie der TU, München, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.20317DOI Listing
September 2004

Does ursodeoxycholic acid change the proliferation of the colorectal mucosa?. A randomized, placebo-controlled study.

Digestion 2003 30;68(4):209-16. Epub 2003 Dec 30.

Department of Medicine II, Klinikum Grosshadern, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000075927DOI Listing
May 2004

Cytotoxic activity of novel human monoclonal antibody MT201 against primary ovarian tumor cells.

J Cancer Res Clin Oncol 2003 Jun 18;129(6):341-8. Epub 2003 Jun 18.

Department of Gynecology and Obstetrics, University of Munich-Grosshadern, 81377 Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-003-0438-6DOI Listing
June 2003

Does endometriosis really have premalignant potential? A clonal analysis of laser-microdissected tissue.

FASEB J 2003 Apr 19;17(6):693-5. Epub 2003 Feb 19.

Department of Pathology, Ludwig-Maximilians University Munich, D-80337 Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1096/fj.02-0562fjeDOI Listing
April 2003

Multicolor deconvolution microscopy of thick biological specimens.

Am J Pathol 2003 Feb;162(2):373-9

Institut für Humangenetik, Technische Universität München, München, Germany.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1851164PMC
http://dx.doi.org/10.1016/S0002-9440(10)63832-1DOI Listing
February 2003

K-RAS mutations in ovarian and extraovarian lesions of serous tumors of borderline malignancy.

Lab Invest 2003 Feb;83(2):251-8

Institute of Pathology, Ludwig-Maximilians-University of Munich, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.lab.0000056994.81259.32DOI Listing
February 2003

Large core biopsy of the pancreas under CT fluoroscopy control: results and complications.

J Comput Assist Tomogr 2002 Sep-Oct;26(5):743-9

Institute of Clinical Radiology, Klinikum of the Ludwig-Maximilian-University-Grosshadern, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00004728-200209000-00014DOI Listing
December 2002

Autofluorescence spectroscopy for the diagnosis of cervical intraepithelial neoplasia.

BJOG 2002 Aug;109(8):947-51

Department of Obstetrics and Gynaecology, University Munich-Grosshadern, 81377 Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1471-0528.2002.01311.xDOI Listing
August 2002

Protein elongation factor EEF1A2 is a putative oncogene in ovarian cancer.

Nat Genet 2002 Jul 10;31(3):301-5. Epub 2002 Jun 10.

Hamilton Regional Cancer Centre, Room 450, 699 Concession Street, Hamilton, Ontario, L8V 5C2, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ng904DOI Listing
July 2002

CT/fluoroscopy-guided transthoracic needle biopsy: sensitivity and complication rate in 98 procedures.

J Comput Assist Tomogr 2002 Mar-Apr;26(2):191-6

Institute for Clinical Radiology, University of Munich-Grosshadern, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00004728-200203000-00005DOI Listing
April 2002

Microsatellite instability, loss of heterozygosity, and loss of hMLH1 and hMSH2 protein expression in endometrial carcinoma.

Hum Pathol 2002 Mar;33(3):347-54

Institute of Pathology and the Department of Clinical Chemistry, Grosshadern Hospital Ludwig-Maximilian University of Munich, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/hupa.2002.32220DOI Listing
March 2002